California SB1306 exempts chemical mixtures containing gamma-butyrolactone from state regulation if the concentration is 70% or less.
California SB1306 amends the Health and Safety Code to exempt chemical mixtures containing gamma-butyrolactone (GBL) from state regulation if the concentration is 70% or less. This change aligns California law with federal exemptions set by the Drug Enforcement Administration (DEA). The bill aims to reduce unnecessary compliance burdens on semiconductor manufacturers in California, who currently face stricter state regulations compared to other states. The exemption applies to mixtures obtained or sold within or outside the state, provided GBL is present at 70% or less by weight or volume.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.